Seyitler Kimyanayi ASIST:SEYKM +5.62%64 ROE % is 21.53% as of Mar. 2026, which is 50% above its 10-year median of 14.39. GuruFocus rates IST:SEYKM with a GF Score™ of 64/100 and a GF Value™ of ₺2.82 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Seyitler Kimyanayi AS ranks better than 60.48% on this metric.
The historical rank and industry rank for Seyitler Kimyanayi AS's ROE % or its related term are showing as below:
IST:SEYKM'
s ROE % Range Over the Past 10 Years
Min: -26.57 Med: 14.39 Max: 53.49
Current: 5.82
During the past 12 years, Seyitler Kimyanayi AS's highest ROE % was 53.49%. The lowest was -26.57%. And the median was 14.39%.
IST:SEYKM's ROE % is ranked better than 60.48% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs IST:SEYKM: 5.82
Seyitler Kimyanayi AS (IST:SEYKM) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Seyitler Kimyanayi AS's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seyitler Kimyanayi AS ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seyitler Kimyanayi AS's ROE % distribution charts can be found below:
* The bar in red indicates where Seyitler Kimyanayi AS's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Seyitler Kimyanayi AS (IST:SEYKM) has a ROE % of 21.53% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Seyitler Kimyanayi AS and its competitors. This is 50% above median its historical median of 14.39. According to the industry distribution chart, Seyitler Kimyanayi AS ranks #315 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 39.5%.
Is Seyitler Kimyanayi AS's ROE % too high?
Seyitler Kimyanayi AS's current ROE % of 21.53% is 50% above median its 10-year median of 14.39. The Medical Devices & Instruments industry median ROE % is 2.40. Seyitler Kimyanayi AS's value of 21.53% is 797.1% above this industry median. Based on the distribution chart, Seyitler Kimyanayi AS ranks #315 out of 797 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Seyitler Kimyanayi AS has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Seyitler Kimyanayi AS's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Seyitler Kimyanayi AS ranks #315 out of 797 companies for ROE %. This puts Seyitler Kimyanayi AS in the upper half of its industry. The industry median ROE % is 2.40. Seyitler Kimyanayi AS's value of 21.53% is 797.1% above this benchmark. While the company's 10-year median is 14.39 vs. the industry median of 2.40, Seyitler Kimyanayi AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seyitler Kimyanayi AS's current ROE % of 21.53% is 797.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Seyitler Kimyanayi AS and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seyitler Kimyanayi AS's current ROE % is 21.53%, which is 50% above median its own 10-year median of 14.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seyitler Kimyanayi AS stock overvalued right now?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS (IST:SEYKM) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺2.82, compared to a current price of ₺4.89 — trading 73.4% above its estimated fair value. The current ROE % is 21.53%, which is 50% above median its 10-year median of 14.39 and 797.1% above the Medical Devices & Instruments industry median of 2.40. Seyitler Kimyanayi AS's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Seyitler Kimyanayi AS (IST:SEYKM), the current ROE % is 21.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seyitler Kimyanayi AS (IST:SEYKM) Overvalued in 2026?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS stock appears to be overvalued.
The current stock price of ₺4.89 is trading 73.4% above its estimated GF Value™ of ₺2.82.
GuruFocus considers Seyitler Kimyanayi AS to be Significantly Overvalued.
Key valuation signals for IST:SEYKM:
ROE %: 21.53% (50% above median its 10-year median of 14.39)
GF Value™: ₺2.82 vs. price of ₺4.89 (73.4% above fair value)
Industry Position: 797.1% above the Medical Devices & Instruments median (#315 of 797)
No single metric tells the full story. See the IST:SEYKM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seyitler Kimya Sanayi AS is engaged in manufacturing Medical plaster, first aid plaster, and capsicum perforated rheumatism plaster. Its products include Medical Tapes, Medical fluids, Wound Dressing, First-Aid plaster and Eye products among others.
64GF Score
Get the complete analysis for IST:SEYKM
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SEYKM has been successfully added to your 
